PN-101 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
50皮膚筋炎/多発性筋炎1

50. 皮膚筋炎/多発性筋炎


臨床試験数 : 182 薬物数 : 229 - (DrugBank : 88) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 147
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04976140
(ClinicalTrials.gov)
August 20211/7/2021Evaluate the Safety, Tolerability and Efficacy of PN-101 in Patients With Refractory Polymyositis or DermatomyositisA Prospective, Open, Dose-escalation, Single-center, Phase 1/2a Trial to Evaluate the Safety, Tolerability and to Explore the Efficacy of PN-101 in Patients With Refractory Polymyositis or DermatomyositisPolymyositis;DermatomyositisBiological: PN-101Paean Biotechnology Inc.NULLNot yet recruiting19 YearsN/AAll18Phase 1/Phase 2NULL